Hong-yi Lin
TPQ 11561, Taiwan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Dual suppression of stemness and redox adaptation in glioblastoma through filaggrin upregulation by an abiraterone-based HDAC inhibitor.
Journal: Journal of biomedical science
Published: June 14, 2025
Contribution of Prostaglandin E2-Induced Neuronal Excitation to Drug Resistance in Glioblastoma Countered by a Novel Blood-Brain Barrier Crossing Celecoxib Derivative.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: April 08, 2025
Repurposing Linezolid in Conjunction with Histone Deacetylase Inhibitor Access in the Realm of Glioblastoma Therapies.
Journal: Journal of medicinal chemistry
Published: January 21, 2025
Progesterone boosts abiraterone-driven target and NK cell therapies against glioblastoma.
Journal: Journal of experimental & clinical cancer research : CR
Published: July 04, 2024
Exploring neuron-specific steroid synthesis and DHEAS therapy in Alzheimer's disease.
Journal: The Journal of steroid biochemistry and molecular biology
Published: April 03, 2024
First-in-Class Dual EZH2-HSP90 Inhibitor Eliciting Striking Antiglioblastoma Activity In Vitro and In Vivo.
Journal: Journal of medicinal chemistry
Published: January 29, 2024
Dual inhibition of CYP17A1 and HDAC6 by abiraterone-installed hydroxamic acid overcomes temozolomide resistance in glioblastoma through inducing DNA damage and oxidative stress.
Journal: Cancer letters
Published: August 24, 2023
CCAAT/Enhancer-Binding Protein Delta Regulates Glioblastoma Survival through Catalase-Mediated Hydrogen Peroxide Clearance.
Journal: Oxidative medicine and cellular longevity
Published: September 07, 2021
Allopregnanolone suppresses glioblastoma survival through decreasing DPYSL3 and S100A11 expression.
Journal: The Journal of steroid biochemistry and molecular biology
Published: July 05, 2021
17β-estradiol induces temozolomide resistance through NRF2-mediated redox homeostasis in glioblastoma.
Journal: Free radical biology & medicine
Published: April 26, 2021
CCAAT/Enhancer-binding protein delta mediates glioma stem-like cell enrichment and ATP-binding cassette transporter ABCA1 activation for temozolomide resistance in glioblastoma.
Journal: Cell death discovery
Published: August 26, 2020
Last Updated: 09/26/2026